Tag: non-hormonal therapy

A meta-analysis of seven randomized placebo-controlled trials found neurokinin receptor antagonists significantly reduced the frequency and severity of menopausal vasomotor ...

A new drug profile describes elinzanetant as the first dual NK-1 and NK-3 receptor antagonist approved for moderate to severe ...